Skip to main content
Signal8
Moller Andrew James profile photo

Andrew James Moller

CIK: 0002054340

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

JBT MAREL Corp logo
JBTM

JBT MAREL Corp

Officer
CONMED Corp logo
CNMD

CONMED Corp

Officer

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • JBT MAREL Corp logo
    JBTM

    JBT MAREL Corp

    Jul 15, 2026
    Award(A)
    Direct
    743 shares-
  • CONMED Corp logo
    CNMD

    CONMED Corp

    Mar 2, 2026
    Award(A)

    RSUs (Restricted Stock Units)

    Direct
    5.9K shares-
  • CONMED Corp logo
    CNMD

    CONMED Corp

    Jan 27, 2025
    Award(A)

    Options To Purchase Common Stock

    Direct
    5K shares-

1-3 of 3

About Moller Andrew James

Moller Andrew James (SEC CIK 0002054340) files insider reports with the SEC as VP & Chief Accounting Officer of JBT MAREL Corp (JBTM) and VP Corporate Controller of CONMED Corp (CNMD).

Signal8 holds 5 ownership filings by Moller Andrew James (2 Form 3, 3 Form 4), filed between Jan 30, 2025 and Jul 17, 2026. Those filings report 3 transactions, from Jan 27, 2025 to Jul 15, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Moller Andrew James's filings is in CHICAGO, IL.

Recent filings by Moller Andrew James

  • Jul 15, 2026: Grant or award of JBTM shares (Form 4, code A).
  • Mar 2, 2026: Grant or award of CNMD derivative securities (Form 4, code A).
  • Jan 27, 2025: Grant or award of CNMD derivative securities (Form 4, code A).

Other insiders filing for JBT MAREL Corp (JBTM)

How to read Form 4 transaction codes